Literature DB >> 31557022

Harnessing the TEMPO-Catalyzed Aerobic Oxidation for Machetti-De Sarlo Reaction toward Sustainable Synthesis of Isoxazole Libraries.

Murugan Vadivelu1, Sugirdha Sampath1,2, Kesavan Muthu3, Kesavan Karthikeyan1, Chandrasekar Praveen4,5.   

Abstract

A practical synthesis of isoxazole/isoxazoline derivatives via Machetti-De Sarlo reaction under sustainable conditions has been accomplished. This protocol involves the use of readily available 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) to catalyze the cyclocondensation of primary nitroalkanes with alkynes/alkenes to afford a library of isoxazole/isoxazoline products. From an eco-benign perspective, notable advantages of this method are as follows: (i) water as the solvent, (ii) air as the oxidant, (iii) transition metal-free, (iv) no base required, (v) no toxic byproduct, (vi) no need of solvent extraction, (vii) diverse substrate scope, (viii) high chemical yields, (ix) excellent chemo- and regioselectivity, (x) short reaction time, (xi) gram-scale synthesis, (xii) extension to heterogeneous version, and (xiii) catalyst recyclability. For these reasons, the developed method is appropriate for safe laboratory use and can be expected to inspire the progress of TEMPO-based organocatalysis for the preparation of isoxazole/isoxazoline moieties in an environmentally benign fashion.

Entities:  

Year:  2019        PMID: 31557022     DOI: 10.1021/acs.joc.9b01896

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Solvent-free synthesis of 3,5-isoxazoles via 1,3-dipolar cycloaddition of terminal alkynes and hydroxyimidoyl chlorides over Cu/Al2O3 surface under ball-milling conditions.

Authors:  Rafael A Hernandez R; Kelly Burchell-Reyes; Arthur P C A Braga; Jennifer Keough Lopez; Pat Forgione
Journal:  RSC Adv       Date:  2022-02-23       Impact factor: 3.361

Review 2.  An overview of metal-free synthetic routes to isoxazoles: the privileged scaffold.

Authors:  Soumyadip Das; Kaushik Chanda
Journal:  RSC Adv       Date:  2021-10-06       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.